All Insights
Life sciences companies turn to public markets for injections of capital
London markets have remained open during the pandemic allowing for a surge in life sciences and healthcare sector deals including
Financial Conduct Authority encouraged by Covid-19 response and sector resilience
UK regulator stresses the importance of contingency planning for the industry, including wealth managers and advisors, and hints that more
Meeting alternatives and COVID-19: Solutions for Belgian companies and their stakeholders
Updated on 29 June 2020. As companies prepare for their annual shareholders' meetings, Belgium's federal government has offered a number
Should a claim be stayed where foreign proceedings arise from the same dispute but are not framed in identical terms?
Osborne Clarke secures a victory in staying a claim brought in England on the basis of proceedings brought in Cyprus
HMRC delivers 'working time' clarification for furloughed EMI option holders
Finance Bill clause gives furloughed employees with Enterprise Management Incentive options welcome clarity on what counts as a 'disqualifying event'
Hold the tiger by the tail: the challenges of end of life funds
As lockdown is lifted and transactional activity returns, tail funds offer a way out of the malaise of the pandemic
Financing the transition to net zero: new guide published
A new guide for the UK's financial sector outlines what firms should be doing in their approach to climate risk
COVID-19 and Corporate Law Considerations
The new Code for Companies and Associations (the "CCA") that was passed in 2019 introduced several key changes to corporate
UK government legislates to shield businesses vital for public health from foreign takeovers
The Covid-19 pandemic has disrupted the global economy and left UK businesses with critical capabilities, such as manufacturers of personal
